Login | Register

Cardio360: ACC 2025 Highlights

Categories: ACC, Highlights
Wishlist Share
Share Course
Page Link
Share On Social Media

About Course

Provide a 360° update on the evidence presented at ACC 2025, synthesizing clinical trials and discussions on cardiovascular interventions—from lipid therapies to valvular procedures and innovations in heart failure—so that participants can align their practices with scientific advances and make more evidence-based clinical decisions.

What Will You Learn?

  • You will explore the key updates presented at ACC 2025, including new therapies for lipid lowering and obesity management, advances in coronary and valvular interventions, innovations in heart failure treatment, antithrombotic strategies, genetics, artificial intelligence in cardiology, pulmonary hypertension, and more. The course offers a 360° review of the most relevant clinical trials and discussions, helping you make more evidence-based decisions in clinical practice.

Course Content

Innovative lipid therapy
Lepodisiran – ALPACA Phase 2 Results AZD0780 – PURSUIT Trial SHR 1918 – Angiopoietin like 3 monoclonal antibody. Solbinsiran – ANGPTL3 siRNA Therapy.

Student Ratings & Reviews

No Review Yet
No Review Yet